sedator 1 mg/ml injektionsvæske, opløsning
eurovet animal health b.v. - medetomidinhydrochlorid - injektionsvæske, opløsning - 1 mg/ml
exparel liposomal
pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.
nordimet
nordic group b.v. - methotrexat - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastiske midler - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
methotrexat "2care4" 2,5 mg tabletter
2care4 aps - methotrexatnatrium - tabletter - 2,5 mg
methotrexate "orion" 25 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte
orion corporation - methotrexat - injektionsvæske, opløsning i fyldt injektionssprøjte - 25 mg/ml
methotrexate "pfizer" 25 mg/ml injektions-/infusionsvæske, opløsning
pfizer aps - methotrexat - injektions-/infusionsvæske, opløsning - 25 mg/ml
methotrexat "orifarm" 2,5 mg tabletter
orifarm a/s - methotrexatnatrium - tabletter - 2,5 mg
metex pen 10 mg injektionsvæske, opløsning i fyldt pen
2care4 aps - methotrexatnatrium - injektionsvæske, opløsning i fyldt pen - 10 mg
methotrexat "mashal" 2,5 mg tabletter
mashal healthcare a/s - methotrexatnatrium - tabletter - 2,5 mg
thelin
pfizer ltd. - sitaxentan-natrium - hypertension, lunge - antihypertensiva, - behandling af patienter med pulmonal arteriel hypertension (pah) klassificeret som who funktionsklasse iii, for at forbedre træningskapaciteten. effektivitet er blevet vist ved primær lunghypertension og i lungehypertension associeret med bindevævssygdom.